Amyloid beta peptides and glutamatergic synaptic dysregulation

Experimental Neurology

Volumn 210, Issue 1, 2008, Pages 7-13

  Parameshwaran, Kodeeswaran ^a   Dhanasekaran, Muralikrishnan ^a   Suppiramaniam, Vishnu ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; AMYLOID BETA PROTEIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; AUTOPHOSPHORYLATION; BRAIN FUNCTION; BRAIN REGION; CELL CULTURE; CELL DEATH; CELL LINE; COGNITIVE DEFECT; DISEASE COURSE; ENZYME ACTIVITY; HUMAN; MEMORY CONSOLIDATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; GLUTAMIC ACID; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 39149117756     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.10.008     Document Type: Review

References (72)

1. Albasanz J.L., Dalfo E., Ferrer I., and Martin M. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes. Neurobiol. Dis. 20 (2005) 685-693
2. Allen J.W., Eldadah B.A., and Faden A.I. Beta-amyloid-induced apoptosis of cerebellar granule cells and cortical neurons: exacerbation by selective inhibition of group I metabotropic glutamate receptors. Neuropharmacology 38 (1999) 1243-1252
3. Almeida C.G., Tampellini D., Takahashi R.H., Greengard P., Lin M.T., Snyder E.M., and Gouras G.K. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 20 (2005) 187-198
4. Armstrong D.M., Ikonomovic M.D., Sheffield R., and Wenthold R.J. AMPA-selective glutamate receptor subtype immunoreactivity in the entorhinal cortex of non-demented elderly and patients with Alzheimer's disease. Brain Res. 639 (1994) 207-216
5. Aronica E., Dickson D.W., Kress Y., Morrison J.H., and Zukin R.S. Non-plaque dystrophic dendrites in Alzheimer hippocampus: a new pathological structure revealed by glutamate receptor immunocytochemistry. Neuroscience 82 (1998) 979-991
6. Bahr B.A., Abai B., Gall C.M., Vanderklish P.W., Hoffman K.B., and Lynch G. Induction of beta-amyloid-containing polypeptides in hippocampus: evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin. Exp. Neurol. 129 (1994) 81-94
7. Bahr B.A., Hoffman K.B., Yang A.J., Hess U.S., Glabe C.G., and Lynch G. Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J. Comp. Neurol. 397 (1998) 139-147
8. Barghorn S., Nimmrich V., Striebinger A., Krantz C., Keller P., Janson B., Bahr M., Schmidt M., Bitner R.S., Harlan J., Barlow E., Ebert U., and Hillen H. Globular amyloid beta-peptide oligomer-a homogenous and stable neuropathological protein in Alzheimer's disease. J. Neurochem. 95 (2005) 834-847
9. Bendiske J., and Bahr B.A. Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis-an approach for slowing Alzheimer disease?. J. Neuropathol. Exp. Neurol. 62 (2003) 451-463
10. Bi X., Chen J., Dang S., Wenthold R.J., Tocco G., and Baudry M. Characterization of calpain-mediated proteolysis of GluR1 subunits of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptors in rat brain. J. Neurochem. 68 (1997) 1484-1494
11. Bi X., Gall C.M., Zhou J., and Lynch G. Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists. Neuroscience 112 (2002) 827-840
12. Bi X., Rong Y., Chen J., Dang S., Wang Z., and Baudry M. Calpain-mediated regulation of NMDA receptor structure and function. Brain Res. 790 (1998) 245-253
13. Blanchard B.J., Chen A., Rozeboom L.M., Stafford K.A., Weigele P., and Ingram V.M. Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 14326-14332
14. Bredt D.S., and Nicoll R.A. AMPA receptor trafficking at excitatory synapses. Neuron 40 (2003) 361-379
15. Calon F., Lim G.P., Morihara T., Yang F., Ubeda O., Salem Jr. N., Frautschy S.A., and Cole G.M. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur. J. Neurosci. 22 (2005) 617-626
16. Carroll R.C., Lissin D.V., von Zastrow M., Nicoll R.A., and Malenka R.C. Rapid redistribution of glutamate receptors contributes to long-term depression in hippocampal cultures. Nat. Neurosci. 2 (1999) 454-460
17. Celsi F., Svedberg M., Unger C., Cotman C.W., Carri M.T., Ottersen O.P., Nordberg A., and Torp R. Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiol. Dis. (2007)
18. Cha J.H., Farrell L.A., Ahmed S.F., Frey A., Hsiao-Ashe K.K., Young A.B., Penney J.B., Locascio J.J., Hyman B.T., and Irizarry M.C. Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein. Neurobiol. Dis. 8 (2001) 90-102
19. Chan S.L., Griffin W.S., and Mattson M.P. Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease. J. Neurosci. Res. 57 (1999) 315-323
20. Chang E.H., Savage M.J., Flood D.G., Thomas J.M., Levy R.B., Mahadomrongkul V., Shirao T., Aoki C., and Huerta P.T. AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3410-3415
21. Choi D.W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18 (1995) 58-60
22. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., and Ashe K.H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8 (2005) 79-84
23. Conn P.J., and Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 205-237
24. Coutinho V., and Knopfel T. Metabotropic glutamate receptors: electrical and chemical signaling properties. Neuroscientist 8 (2002) 551-561
25. Dingledine R., Borges K., Bowie D., and Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51 (1999) 7-61
26. Giovannelli L., Casamenti F., Scali C., Bartolini L., and Pepeu G. Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis. Neuroscience 66 (1995) 781-792
27. Goto Y., Niidome T., Akaike A., Kihara T., and Sugimoto H. Amyloid beta-peptide preconditioning reduces glutamate-induced neurotoxicity by promoting endocytosis of NMDA receptor. Biochem. Biophys. Res. Commun. 351 (2006) 259-265
28. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
29. Harkany T., Abraham I., Timmerman W., Laskay G., Toth B., Sasvari M., Konya C., Sebens J.B., Korf J., Nyakas C., Zarandi M., Soos K., Penke B., and Luiten P.G. Beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur. J. Neurosci. 12 (2000) 2735-2745
30. Hayashi Y., Shi S.H., Esteban J.A., Piccini A., Poncer J.C., and Malinow R. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 287 (2000) 2262-2267
31. Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S., and Malinow R. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52 (2006) 831-843
32. Johansson S., Radesater A.C., Cowburn R.F., Thyberg J., and Luthman J. Modelling of amyloid beta-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats. Exp. Brain Res. 168 (2006) 11-24
33. Kanju P.M., Parameshwaran K., Vaithianathan T., Sims C.M., Huggins K., Bendiske J., Ryzhikov S., Bahr B.A., and Suppiramaniam V. Lysosomal dysfunction produces distinct alterations in synaptic alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid and N-methyl-D-aspartate receptor currents in hippocampus. J. Neuropathol. Exp. Neurol. 66 (2007) 779-788
34. Kim J.H., Anwyl R., Suh Y.H., Djamgoz M.B., and Rowan M.J. Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J. Neurosci. 21 (2001) 1327-1333
35. Larson J., Lynch G., Games D., and Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840 (1999) 23-35
36. Lee R.K., Jimenez J., Cox A.J., and Wurtman R.J. Metabotropic glutamate receptors regulate APP processing in hippocampal neurons and cortical astrocytes derived from fetal rats. Ann. N. Y. Acad. Sci. 777 (1996) 338-343
37. Lee R.K., Wurtman R.J., Cox A.J., and Nitsch R.M. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8083-8087
38. Lee V.M., Goedert M., and Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24 (2001) 1121-1159
39. Lesne S., Ali C., Gabriel C., Croci N., MacKenzie E.T., Glabe C.G., Plotkine M., Marchand-Verrecchia C., Vivien D., and Buisson A. NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J. Neurosci. 25 (2005) 9367-9377
40. Louzada Jr. P.R., Paula Lima A.C., de Mello F.G., and Ferreira S.T. Dual role of glutamatergic neurotransmission on amyloid beta(1-42) aggregation and neurotoxicity in embryonic avian retina. Neurosci. Lett. 301 (2001) 59-63
41. Miguel-Hidalgo J.J., Alvarez X.A., Cacabelos R., and Quack G. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Brain Res. 958 (2002) 210-221
42. Miller E.K., and Cohen J.D. An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci. 24 (2001) 167-202
43. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., and McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20 (2000) 4050-4058
44. Parameshwaran K., Sims C., Kanju P., Vaithianathan T., Shonesy B.C., Dhanasekaran M., Bahr B.A., and Suppiramaniam V. Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function. Synapse 61 (2007) 367-374
45. Pin J.P., and Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34 (1995) 1-26
46. Pizzi M., Sarnico I., Boroni F., Benarese M., Steimberg N., Mazzoleni G., Dietz G.P., Bahr M., Liou H.C., and Spano P.F. NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity. Cell Death Differ. 12 (2005) 761-772
47. Rao S.G., Williams G.V., and Goldman-Rakic P.S. Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J. Neurosci. 20 (2000) 485-494
48. Roselli F., Tirard M., Lu J., Hutzler P., Lamberti P., Livrea P., Morabito M., and Almeida O.F. Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J. Neurosci. 25 (2005) 11061-11070
49. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
50. Selkoe D.J. Toward a remembrance of things past: deciphering Alzheimer disease. Harvey Lect. 99 (2003) 23-45
51. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995) 754-760
52. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P.J., Neki A., Abe T., Nakanishi S., and Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci. 17 (1997) 7503-7522
53. Sivaprakasam K. Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation. Curr. Med. Chem. 13 (2006) 2179-2188
54. Smith A.D. Prevention of dementia: a role for B vitamins?. Nutr. Health 18 (2006) 225-226
55. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., and Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8 (2005) 1051-1058
56. Song I., and Huganir R.L. Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci. 25 (2002) 578-588
57. St George-Hyslop P.H. Molecular genetics of Alzheimer's disease. Biol. Psychiatry 47 (2000) 183-199
58. Szegedi V., Juhasz G., Budai D., and Penke B. Divergent effects of Abeta1-42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo. Brain Res. 1062 (2005) 120-126
59. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., Beal M.F., Xu H., Greengard P., and Gouras G.K. Intraneuronal Alzheimer Abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161 (2002) 1869-1879
60. Tang B.L., and Liou Y.C. Novel modulators of amyloid-beta precursor protein processing. J. Neurochem. 100 (2007) 314-323
61. Thorns V., Mallory M., Hansen L., and Masliah E. Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer's disease and Lewy body variant. Acta Neuropathol. (Berl) 94 (1997) 539-548
62. Ting J.T., Kelley B.G., Lambert T.J., Cook D.G., and Sullivan J.M. Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 353-358
63. Townsend M., Shankar G.M., Mehta T., Walsh D.M., and Selkoe D.J. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 572 (2006) 477-492
64. Tozaki H., Matsumoto A., Kanno T., Nagai K., Nagata T., Yamamoto S., and Nishizaki T. The inhibitory and facilitatory actions of amyloid-beta peptides on nicotinic ACh receptors and AMPA receptors. Biochem. Biophys. Res. Commun. 294 (2002) 42-45
65. Tyszkiewicz J.P., and Yan Z. Beta-amyloid peptides impair PKC-dependent functions of metabotropic glutamate receptors in prefrontal cortical neurons. J. Neurophysiol. 93 (2005) 3102-3111
66. Verdier Y., and Penke B. Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease. Curr. Protein Pept. Sci. 5 (2004) 19-31
67. Wenk G.L., Parsons C.G., and Danysz W. Potential role of N-methyl-d-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine. Behav. Pharmacol. 17 (2006) 411-424
68. Yaari R., and Corey-Bloom J. Alzheimer's disease. Semin. Neurol. 27 (2007) 32-41
69. Yan Z., and Feng J. Alzheimer's disease: interactions between cholinergic functions and beta-amyloid. Curr. Alzheimer Res. 1 (2004) 241-248
70. Yao P.J., Zhu M., Pyun E.I., Brooks A.I., Therianos S., Meyers V.E., and Coleman P.D. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol. Dis. 12 (2003) 97-109
71. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., and Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53 (2007) 337-351
72. Zhao D., Watson J.B., and Xie C.W. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation. J. Neurophysiol. 92 (2004) 2853-2858